Skip navigation

Chemical Cisplatin

1–50 of 14,030 results.
  Interacting Chemical Interacting Gene Interaction References Organisms
1. Cisplatin A1CF [Cisplatin co-treated with jinfukang] results in decreased expression of A1CF mRNA 1 1
2. Cisplatin A1CF Cisplatin results in decreased expression of A1CF mRNA 1 1
3. Cisplatin A2M Cisplatin binds to A2M protein 1 1
4. Cisplatin A2M Cisplatin results in increased expression of A2M mRNA 1 1
5. Cisplatin A4GALT Cisplatin affects the expression of A4GALT mRNA 1 1
6. Cisplatin A4GALT [Cisplatin co-treated with jinfukang] results in increased expression of A4GALT mRNA 1 1
7. Cisplatin AAK1 Cisplatin results in increased expression of AAK1 mRNA 1 1
8. BEP protocol AARD BEP protocol results in increased expression of AARD mRNA 1 1
9. Cisplatin AARS Cisplatin affects the expression of AARS mRNA 1 1
10. Cisplatin AARS Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS mRNA] 1 1
11. Cisplatin AARS Cisplatin results in decreased expression of AARS mRNA 1 1
12. Cisplatin AASS Cisplatin results in decreased expression of AASS mRNA 1 1
13. Cisplatin AATBC [Cisplatin co-treated with jinfukang] results in decreased expression of AATBC mRNA 1 1
14. Cisplatin AATBC Cisplatin results in decreased expression of AATBC mRNA 1 1
15. Cisplatin ABAT [Cisplatin co-treated with jinfukang] results in decreased expression of ABAT mRNA 1 1
16. Cisplatin ABAT Cisplatin results in decreased expression of ABAT mRNA 1 1
17. Cisplatin ABCA12 [Cisplatin co-treated with jinfukang] results in increased expression of ABCA12 mRNA 1 1
18. Cisplatin ABCA12 Cisplatin results in increased expression of ABCA12 mRNA 1 1
19. Cisplatin ABCA13 [Cisplatin co-treated with jinfukang] results in increased expression of ABCA13 mRNA 1 1
20. Cisplatin ABCA13 Cisplatin results in increased expression of ABCA13 mRNA 1 1
21. Cisplatin ABCA2 [Cisplatin co-treated with jinfukang] results in increased expression of ABCA2 mRNA 1 1
22. Cisplatin ABCA2 Cisplatin results in increased expression of ABCA2 mRNA 1 1
23. Cisplatin ABCA6 ABCA6 mRNA affects the susceptibility to Cisplatin 1 1
24. Cisplatin ABCA7 [Cisplatin co-treated with jinfukang] results in increased expression of ABCA7 mRNA 1 1
25. Cisplatin ABCA7 Cisplatin results in increased expression of ABCA7 mRNA 1 1
26. Cisplatin ABCB1 ABCB1 affects the reaction [HIF1A affects the susceptibility to Cisplatin] 1 1
27. Cisplatin ABCB1 ABCB1 affects the susceptibility to Cisplatin 1 1
28. Cisplatin ABCB1 ABCB1 gene polymorphism affects the susceptibility to Cisplatin 1 1
29. Cisplatin ABCB1 ABCB1 gene SNP affects the susceptibility to [Cisplatin co-treated with Fluorouracil] 1 1
30. Cisplatin ABCB1 ABCB1 protein inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] 1 2
31. Cisplatin ABCB1 ABCB1 protein inhibits the reaction [Cisplatin results in increased activity of and results in increased cleavage of CASP3 protein] 1 2
32. Cisplatin ABCB1 ABCB1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] 1 2
33. Cisplatin ABCB1 ABCB1 protein promotes the reaction [Cisplatin results in increased expression of TRP53 protein] 1 2
34. Cisplatin ABCB1 ABCB1 protein results in decreased susceptibility to Cisplatin 3 3
35. Cisplatin ABCB1 Cisplatin inhibits the reaction [ABCB1 protein results in increased susceptibility to NSC73306] 1 1
36. Cisplatin ABCB1 Cisplatin promotes the reaction [[APEX1 protein modified form promotes the reaction [YBX1 protein binds to EP300 protein]] which binds to ABCB1 promoter] 1 1
37. Cisplatin ABCB1 [Cisplatin results in increased acetylation of APEX1 protein] promotes the reaction [APEX1 protein modified form binds to ABCB1 promoter] 1 1
38. Cisplatin ABCB1 [Cisplatin results in increased acetylation of APEX1 protein] promotes the reaction [[APEX1 protein modified form binds to ABCB1 promoter] which results in increased expression of ABCB1 mRNA] 1 1
39. Cisplatin ABCB1 Cisplatin results in increased expression of ABCB1 mRNA 1 1
40. Cisplatin ABCB1 Cisplatin results in increased expression of ABCB1 protein 3 1
41. Cisplatin ABCB1 [CXCL8 results in increased expression of ABCB1 mRNA] which results in decreased susceptibility to Cisplatin 1 1
42. Cisplatin ABCB1 [CXCL8 results in increased expression of ABCB1 protein] which results in decreased susceptibility to Cisplatin 1 1
43. Cisplatin ABCB1 [Diethylnitrosamine co-treated with Cisplatin] results in increased expression of ABCB1 protein 1 1
44. Cisplatin ABCB1 [Paclitaxel results in increased expression of ABCB1] which results in decreased susceptibility to Cisplatin 1 1
45. FPEPIR regimen ABCB1 FPEPIR regimen results in increased expression of ABCB1 mRNA 1 1
46. FPEPIR regimen ABCB1 FPEPIR regimen results in increased expression of ABCB1 protein 1 1
47. Cisplatin ABCB10 ABCB10 mRNA affects the susceptibility to Cisplatin 1 1
48. Cisplatin ABCB1B Cisplatin results in decreased expression of ABCB1B protein 1 1
49. Cisplatin ABCB1B Cisplatin results in increased expression of ABCB1B mRNA 2 2
50. Cisplatin ABCB6 ABCB6 mRNA affects the susceptibility to Cisplatin 1 1
1–50 of 14,030 results.
Download: CSV| Excel| XML| TSV